The FDA today approved Zelboraf (vemurafenib) for the treatment of advanced or metastatic melanoma. The drug extends survival for the 50% of melanoma patients whose tumors carry the BRAF mutation.
Source: http://www.webmd.com/melanoma-skin-cancer/news/20110817/zelboraf-approved-for-late-stage-melanoma?src=RSS_PUBLIC
Spa and Wellness Speech Pathology Supplements Thyroid Weight Loss Womens Issues
No comments:
Post a Comment